Dupilumab for the Treatment of Chronic Inducible Cold Urticaria in Patients Who Remain Symptomatic Despite the Use of H1-antihistamine (LIBERTY-CINDU CUrIADS)
Clinical trial NCT04681729 · COMPLETED
Trial details
- NCT number
- NCT04681729
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-10
- Primary completion
- 2023-02-02
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.